YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches

S Piccolo, T Panciera, P Contessotto, M Cordenonsi - Nature cancer, 2023 - nature.com
Our understanding of the function of the transcriptional regulators YAP and TAZ (YAP/TAZ)
in cancer is advancing. In this Review, we provide an update on recent progress in YAP/TAZ …

Hippo signalling in the liver: role in development, regeneration and disease

JO Russell, FD Camargo - Nature reviews Gastroenterology & …, 2022 - nature.com
The Hippo signalling pathway has emerged as a major player in many aspects of liver
biology, such as development, cell fate determination, homeostatic function and …

[HTML][HTML] Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations

S Affo, A Nair, F Brundu, A Ravichandra… - Cancer cell, 2021 - cell.com
Cancer-associated fibroblasts (CAF) are a poorly characterized cell population in the context
of liver cancer. Our study investigates CAF functions in intrahepatic cholangiocarcinoma …

[HTML][HTML] Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis

Y Chen, H Wang, Q Yang, W Zhao, Y Chen, Q Ni… - Theranostics, 2022 - ncbi.nlm.nih.gov
Single-cell RNA sequencing (scRNA-seq) enables specific profiling of cell populations at
single-cell resolution. The osteoimmunology microenvironment in the occurrence and …

YAP/TAZ: drivers of tumor growth, metastasis, and resistance to therapy

BJ Thompson - Bioessays, 2020 - Wiley Online Library
The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently
activated during the growth and progression of many solid tumors, including lung, colorectal …

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice

IM Moya, SA Castaldo, L Van den Mooter, S Soheily… - Science, 2019 - science.org
The Hippo signaling pathway and its two downstream effectors, the YAP and TAZ
transcriptional coactivators, are drivers of tumor growth in experimental models. Studying …

Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis

SH Patel, FD Camargo, D Yimlamai - Gastroenterology, 2017 - Elsevier
The Hippo signaling pathway, also known as the Salvador− Warts− Hippo pathway, is a
regulator of organ size. The pathway takes its name from the Drosophila protein kinase …

[HTML][HTML] YAP, but not RSPO-LGR4/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury

L Planas-Paz, T Sun, M Pikiolek, NR Cochran… - Cell stem cell, 2019 - cell.com
Biliary epithelial cells (BECs) form bile ducts in the liver and are facultative liver stem cells
that establish a ductular reaction (DR) to support liver regeneration following injury. Liver …

The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size

L Planas-Paz, V Orsini, L Boulter, D Calabrese… - Nature cell …, 2016 - nature.com
LGR4/5 receptors and their cognate RSPO ligands potentiate Wnt/β-catenin signalling and
promote proliferation and tissue homeostasis in epithelial stem cell compartments. In the …

The Hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2

WH Yang, CC Lin, J Wu, PY Chao, K Chen… - Molecular Cancer …, 2021 - AACR
Ferroptosis is a new form of regulated cell death resulting from the accumulation of lipid-
reactive oxygen species. A growing number of studies indicate ferroptosis as an important …